Abstract:The two episodes of syncope in strategy A occurred secondary to fast VT unsuccessfully treated by ATP. †Fisher exact test. CI ϭ confidence interval; CL ϭ cycle length; FVT ϭ fast ventricular tachycardia; HES ϭ high-energy shocks; OR ϭ odds ratio.
“…Similarly, a significant proportion (80-87%) of VT/fast VT episodes were successfully ATP-terminated without shock delivery, regardless of whether DT was performed. This is consistent with previous studies showing that dedicated ATP programming reduce the need for shocks to terminate VT/VF in a substantial number of patients [7,17,23]. In addition, newer devices are able to deliver ATP during energy charge when treating a VF episode, in an attempt to terminate a fast VT detected in the VF zone [24,25].…”
Section: Icd Therapy Efficacy In Dt+ Vs Dtpatientssupporting
confidence: 91%
“…The remaining ICD parameters settings were left at the physicians' discretion and were not available for analyses. Nevertheless, the recommended ATP programming strategy was able to successfully terminate a high proportion of treated episodes in previous studies [7,17,26]. Finally, 3 patients died for unknown causes, but witnesses' reports reasonably excluded a sudden cause of death.…”
Section: Limitations Of the Studymentioning
confidence: 89%
“…Device programming was performed according to patient clinical status and left at the discretion of the responsible physician, but all shocks were programmed at the highest available output of the device. However, a standardized ATP programming in the fast ventricular tachycardia (VT) zone was recommended in all patients [17]. Patients were first followed 3 months after device implantation and every 6 months thereafter.…”
Section: Methodsmentioning
confidence: 99%
“…Patients in the DT+ group were followed for a longer period than DT-patients (32 vs. 15 [9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26] months; p < 0.001). After adjusting the event rate by the follow-up duration, there was no significant difference in the death rate per observation year (DT+: 0.04 vs. DT-: 0.04; p = 0.91) nor in the rate of patients with ventricular arrhythmic events per observation year (DT+: 0.10 vs. DT-: 0.12; p = 0.46) ( Table 2).…”
“…Similarly, a significant proportion (80-87%) of VT/fast VT episodes were successfully ATP-terminated without shock delivery, regardless of whether DT was performed. This is consistent with previous studies showing that dedicated ATP programming reduce the need for shocks to terminate VT/VF in a substantial number of patients [7,17,23]. In addition, newer devices are able to deliver ATP during energy charge when treating a VF episode, in an attempt to terminate a fast VT detected in the VF zone [24,25].…”
Section: Icd Therapy Efficacy In Dt+ Vs Dtpatientssupporting
confidence: 91%
“…The remaining ICD parameters settings were left at the physicians' discretion and were not available for analyses. Nevertheless, the recommended ATP programming strategy was able to successfully terminate a high proportion of treated episodes in previous studies [7,17,26]. Finally, 3 patients died for unknown causes, but witnesses' reports reasonably excluded a sudden cause of death.…”
Section: Limitations Of the Studymentioning
confidence: 89%
“…Device programming was performed according to patient clinical status and left at the discretion of the responsible physician, but all shocks were programmed at the highest available output of the device. However, a standardized ATP programming in the fast ventricular tachycardia (VT) zone was recommended in all patients [17]. Patients were first followed 3 months after device implantation and every 6 months thereafter.…”
Section: Methodsmentioning
confidence: 99%
“…Patients in the DT+ group were followed for a longer period than DT-patients (32 vs. 15 [9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26] months; p < 0.001). After adjusting the event rate by the follow-up duration, there was no significant difference in the death rate per observation year (DT+: 0.04 vs. DT-: 0.04; p = 0.91) nor in the rate of patients with ventricular arrhythmic events per observation year (DT+: 0.10 vs. DT-: 0.12; p = 0.46) ( Table 2).…”
“…The initial ATP therapy in the fast VT zone was a single ATP sequence (5-pulse-burst pacing train at 84 % of the VT CL) [9]. Failed ATP was followed by shock and then other shocks as necessary.…”
VTs occurring in SP patients are slower, more stable, and they terminate less frequently at ATP. Therefore, compared with PP, SP patients seem to have fewer self-terminating VTs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.